LBI-HTA - Publications - Search - Person: McGahan, Lynda
Number of items: 2.

McGahan, Lynda (2017): Palbociclib (Ibrance®) in combination with fulvestrant for the treatment of hormone-receptor-positive, HER2-negative advanced or metastatic breast cancer. DSD: Horizon Scanning in Oncology 64.

McGahan, Lynda (2016): Atezolizumab (Tecentriq™) for the treatment of locally advanced and metastatic urothelial carcinoma. DSD: Horizon Scanning in Oncology 61.

This list was generated on Sat Mar 25 20:01:28 2017 CET.